Home
Categories
EXPLORE
True Crime
Comedy
Society & Culture
Business
Sports
TV & Film
Technology
About Us
Contact Us
Copyright
© 2024 PodJoint
00:00 / 00:00
Sign in

or

Don't have an account?
Sign up
Forgot password
https://is1-ssl.mzstatic.com/image/thumb/Podcasts112/v4/63/75/83/637583e1-ca5a-0aa3-145a-bc1b69bb9eb0/mza_16068022241733376828.jpg/600x600bb.jpg
GFN News
GFN.TV
364 episodes
22 hours ago
In this episode of Science Lab, we break down the latest research comparing traditional cigarette smoking with heated tobacco products (HTPs). Using evidence from multiple clinical studies, she explains how switching completely from smoking to HTPs affects biomarkers of exposure, biomarkers of potential harm, reported symptoms, and overall risk profiles.
Show more...
News
RSS
All content for GFN News is the property of GFN.TV and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
In this episode of Science Lab, we break down the latest research comparing traditional cigarette smoking with heated tobacco products (HTPs). Using evidence from multiple clinical studies, she explains how switching completely from smoking to HTPs affects biomarkers of exposure, biomarkers of potential harm, reported symptoms, and overall risk profiles.
Show more...
News
https://i1.sndcdn.com/artworks-hikqgZ7Xr50r71Zq-zgT31Q-t3000x3000.png
#GFN25 Science Discussion #4 | Introduction to Zanoprima's Synthetic Nicotine
GFN News
10 minutes 45 seconds
2 weeks ago
#GFN25 Science Discussion #4 | Introduction to Zanoprima's Synthetic Nicotine
#GFN25 Science Discussion #4 | Introduction to Zanoprima's Synthetic Nicotine by GFN.TV
GFN News
In this episode of Science Lab, we break down the latest research comparing traditional cigarette smoking with heated tobacco products (HTPs). Using evidence from multiple clinical studies, she explains how switching completely from smoking to HTPs affects biomarkers of exposure, biomarkers of potential harm, reported symptoms, and overall risk profiles.